Condensed Consolidated Statement of Changes in Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Series B Convertible Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Noncontrolling Interest [Member]	Total
Beginning balance, value at Dec. 31, 2019	$ 2,296	$ 41	$ 47,554	$ (53,715)	$ (814)	$ (4,638)
Begining balance, shares at Dec. 31, 2019	1,158,209	40,478,861
Series B Convertible Preferred Stock dividends declared	$ 140			(140)
Series B Convertible Preferred Stock dividends declared, shares	46,663
Issue common stock – conversion Series B Convertible Preferred Stock	$ (43)		43
Issue common stock - conversion Series B Convertible Preferred Stock, shares	(25,000)	25,000
Vesting of restricted stock awards
Vesting of restricted stock awards, shares		233,334
Issue common stock – upon partial conversions of Senior Secured Convertible Note		$ 6	11,567			11,573
Issue common stock upon partial conversions of Senior Secured Convertible Note, shares		5,828,542
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			840			840
Issue common stock – majority-owned subsidiary exercise of stock options					5	5
Issue common stock – Employee Stock Purchase Plan			126			126
Issue common stock - Employee Stock Purchase Plan, shares		154,266
Issue common stock – exercise Series S warrants		$ 1	11			12
Issue common stock - exercise Series S warrants, shares		1,199,383
Stock-based compensation - majority-owned subsidiary			6		26	32
Loss				(20,053)	(702)	(20,755)
Ending balance, value at Jun. 30, 2020	$ 2,393	$ 48	60,147	(73,908)	(1,485)	(12,805)
Ending balance, shares at Jun. 30, 2020	1,179,872	47,919,386
Beginning balance, value at Mar. 31, 2020	$ 2,322	$ 44	50,896	(68,259)	(1,232)	(16,229)
Begining balance, shares at Mar. 31, 2020	1,156,391	44,133,745
Series B Convertible Preferred Stock dividends declared	$ 71			(71)
Series B Convertible Preferred Stock dividends declared, shares	23,481
Issue common stock – upon partial conversions of Senior Secured Convertible Note		$ 4	8,735			8,739
Issue common stock upon partial conversions of Senior Secured Convertible Note, shares		3,785,641
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			513			513
Stock-based compensation - majority-owned subsidiary			3		13	16
Loss				(5,578)	(266)	(5,844)
Ending balance, value at Jun. 30, 2020	$ 2,393	$ 48	60,147	(73,908)	(1,485)	(12,805)
Ending balance, shares at Jun. 30, 2020	1,179,872	47,919,386
Beginning balance, value at Dec. 31, 2020	$ 2,537	$ 64	87,570	(88,275)	(2,369)	(473)
Begining balance, shares at Dec. 31, 2020	1,228,075	63,819,935
Ending balance, value at Mar. 31, 2021	$ 2,587	$ 81	145,396	(97,778)	(2,246)	48,040
Ending balance, shares at Mar. 31, 2021	1,241,438	81,424,744
Beginning balance, value at Dec. 31, 2020	$ 2,537	$ 64	87,570	(88,275)	(2,369)	(473)
Begining balance, shares at Dec. 31, 2020	1,228,075	63,819,935
Series B Convertible Preferred Stock dividends declared	$ 148			(148)
Series B Convertible Preferred Stock dividends declared, shares	49,244
Issue common stock – conversion Series B Convertible Preferred Stock	$ (186)		186
Issue common stock - conversion Series B Convertible Preferred Stock, shares	(91,634)	91,634
Issue common stock – registered offerings, net		$ 16	53,688			53,704
Issue common stock - registered offerings, net, shares		15,782,609
Vesting of restricted stock awards
Vesting of restricted stock awards, shares		150,000
Issue common stock – exercise Series Z warrants		$ 2	2,783			2,785
Issue common stock - exercise Series Z warrants, shares		1,740,658
Issue common stock – upon partial conversions of Senior Secured Convertible Note		$ 1	1,722			1,723
Issue common stock upon partial conversions of Senior Secured Convertible Note, shares		667,668
Issue common stock – PAVmed Inc. 2014 Equity Plan stock option exercises			131			131
Issue common stock - PAVmed Inc. 2014 Equity Plan stock option exercises, shares		120,832
Investment in Veris Health Inc. subsidiary					6	6
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			3,254			3,254
Issue common stock – Employee Stock Purchase Plan			304			304
Issue common stock - Employee Stock Purchase Plan, shares		203,480
Stock-based compensation - majority-owned subsidiary			56		3,329	3,385
Loss				(20,902)	(1,877)	(22,779)
Ending balance, value at Jun. 30, 2021	$ 2,499	$ 83	149,694	(109,325)	(911)	42,040
Ending balance, shares at Jun. 30, 2021	1,185,685	82,576,816
Beginning balance, value at Mar. 31, 2021	$ 2,587	$ 81	145,396	(97,778)	(2,246)	48,040
Begining balance, shares at Mar. 31, 2021	1,241,438	81,424,744
Series B Convertible Preferred Stock dividends declared	$ 76			(76)
Series B Convertible Preferred Stock dividends declared, shares	25,046
Issue common stock – conversion Series B Convertible Preferred Stock	$ (164)		164
Issue common stock - conversion Series B Convertible Preferred Stock, shares	(80,799)	80,799
Vesting of restricted stock awards
Vesting of restricted stock awards, shares		150,000
Issue common stock – exercise Series Z warrants		$ 2	1,409			1,411
Issue common stock - exercise Series Z warrants, shares		880,441
Issue common stock – PAVmed Inc. 2014 Equity Plan stock option exercises			51			51
Issue common stock - PAVmed Inc. 2014 Equity Plan stock option exercises, shares		40,832
Investment in Veris Health Inc. subsidiary					6	6
Stock-based compensation - PAVmed Inc. 2014 Equity Plan			2,622			2,622
Stock-based compensation - majority-owned subsidiary			52		2,528	2,580
Loss				(11,471)	(1,199)	(12,670)
Ending balance, value at Jun. 30, 2021	$ 2,499	$ 83	$ 149,694	$ (109,325)	$ (911)	$ 42,040
Ending balance, shares at Jun. 30, 2021	1,185,685	82,576,816